KaNDy Therapeutics

KaNDy Therapeutics
KaNDy Therapeutics
KaNDy Therapeutics is a clinical-stage company focused on optimising the potential of NT-814 in the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on treating multiple symptoms of the menopause.
Stevenage
BioTech, MedTech, FemTech, Menopause, Healthcare
2017
www.kandytherapeutics.com

Articles about KaNDy Therapeutics:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as KaNDy Therapeutics? We’re happy to assist you with our Startup Sourcing service.